UroGen Pharma to Present at Upcoming Investor Conferences

PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in September. Wells Fargo Healthcare Conference Date / Time: September 3rd, at 2:15 PM ET Format: Fireside Chat Location: Boston, MA Cantor Fitzgerald Global Healthcare Conference Date / Time: September 4th, at 3:55 PM ...